105 related articles for article (PubMed ID: 4801666)
1. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
[No Abstract] [Full Text] [Related]
2. A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
De Ponti C; Bardi U; Marchetti M
Arzneimittelforschung; 1976; 26(11):2089-92. PubMed ID: 1037254
[TBL] [Abstract][Full Text] [Related]
3. A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).
Dorigotti L; Rolandi R; Carpi C
Pharmacol Res Commun; 1976 Jun; 8(3):295-308. PubMed ID: 17122
[No Abstract] [Full Text] [Related]
4. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)].
Baldoli E; Sardi A; Caravaggi AM; Bianchi G
Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088
[No Abstract] [Full Text] [Related]
5. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
Bellasio E; Campi A
Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of oxdralazine and hydralazine in hypertension.
Moskowitz RM; Cohn JN
Clin Pharmacol Ther; 1980 Jun; 27(6):773-8. PubMed ID: 7379444
[TBL] [Abstract][Full Text] [Related]
7. Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.
Assandri A; Perazzi A; Buniva G; Pagani V
Eur J Drug Metab Pharmacokinet; 1979; 4(2):75-82. PubMed ID: 488135
[No Abstract] [Full Text] [Related]
8. Antihypertensive and antidiuretic effects of 3-hydrazino-6-[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) in rats.
Watanabe TX; Shiono K; Saito K; Sokabe H
Jpn J Pharmacol; 1978 Jun; 28(3):413-22. PubMed ID: 702944
[TBL] [Abstract][Full Text] [Related]
9. [On the hypotensive action of some hydrazino-pyridazine derivatives. I].
Manoilă V; Popovici GG
Rev Med Chir Soc Med Nat Iasi; 1968; 72(1):193-8. PubMed ID: 5650665
[No Abstract] [Full Text] [Related]
10. [3-Hydrazinepyridazine derivatives. III. Synthesis and anti-hypertensive activity of new 3-(2-acylhydrazine)-pyridazine-6-alkylamino substitutes].
Parravicini F; Scarpitta G; Dorigotti L; Pifferi G
Farmaco Sci; 1979 Apr; 34(4):299-310. PubMed ID: 553832
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of hydrazine pyridazine with hypotensive activity. II].
Bellasio E; Ripamonti A; Parravicini F; Baldoli E
Farmaco Sci; 1972 Jul; 27(7):591-600. PubMed ID: 5079482
[No Abstract] [Full Text] [Related]
12. Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
Beretta E; Cristina T; Ferrari P; Tuan G; Zerilli LF; Martinelli E
Eur J Drug Metab Pharmacokinet; 1979; 4(1):29-33. PubMed ID: 38122
[TBL] [Abstract][Full Text] [Related]
13. The effects of 3-hydrazine-6[N,N-bis(2-hydroxyethyl)-amino]-pyridazine dihydrochloride (L6150) on the general and cardiac haemodynamics of the intact dog.
Maxwell GM
Clin Exp Pharmacol Physiol; 1976; 3(4):343-8. PubMed ID: 975622
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3-hydrazino-6[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) on renin in hypertensive rats.
Kawashima K; Watanabe TX; Sokabe H
Jpn J Pharmacol; 1980 Feb; 30(1):116-8. PubMed ID: 6995653
[No Abstract] [Full Text] [Related]
15. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
Carpi C; Dorigotti L
Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
[No Abstract] [Full Text] [Related]
16. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives.
Ravina E; Fueyo J; Teran C; Cid J; Garcia Mera G; Orallo F; Bardan B
Pharmazie; 1992 Aug; 47(8):574-7. PubMed ID: 1438508
[No Abstract] [Full Text] [Related]
17. Effects of 3-[N-(2-chlorobenzyl)amino]-6-(1H-imidazol-1-yl) pyridazine dihydrochloride on various aromatase enzyme systems and experimental breast cancer.
Bandoh K; Ishizuka Y; Sato M
Arzneimittelforschung; 1995 Aug; 45(8):897-900. PubMed ID: 7575757
[TBL] [Abstract][Full Text] [Related]
18. Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150.
Maseri A; Pesola A; L'Abbate A; Contini C; Magini G
J Int Med Res; 1976; 4(6):402-9. PubMed ID: 1027634
[TBL] [Abstract][Full Text] [Related]
19. General pharmacological properties of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol (ditazol).
Caprino L; Borrelli F; Falchetti R
Arzneimittelforschung; 1973 Sep; 23(9):1283-7. PubMed ID: 4801221
[No Abstract] [Full Text] [Related]
20. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
Orallo F; Calleja JM; García Mera G; Raviña E
Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
